Axiom Investors’s Progyny PGNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-104,637
Closed -$5.38M 124
2022
Q1
$5.38M Sell
104,637
-19,165
-15% -$821K 0.13% 74
2021
Q4
$6.23M Sell
123,802
-18,253
-13% -$1.02M 0.11% 82
2021
Q3
$7.96M Buy
142,055
+23,990
+20% +$1.33M 0.13% 76
2021
Q2
$6.97M Buy
118,065
+54,260
+85% +$3.05M 0.11% 79
2021
Q1
$2.84M Sell
63,805
-84,473
-57% -$3.95M 0.05% 114
2020
Q4
$6.29M Buy
148,278
+28,304
+24% +$921K 0.1% 82
2020
Q3
$3.53M Buy
119,974
+28,509
+31% +$786K 0.06% 82
2020
Q2
$2.36M Buy
91,465
+35,165
+62% +$807K 0.05% 93
2020
Q1
$1.19M Sell
56,300
-3,125
-5% -$85.9K 0.03% 100
2019
Q4
$1.63M Buy
+59,425
New +$1.42M 0.04% 109

Other funds holding PGNY

Axiom Investors's PGNY Position: Q2 2022 in Review

Axiom Investors sold out of Progyny (PGNY) in Q2 2022, closing a stake of 104,637 shares — an estimated $5.38M sold.

Axiom Investors first reported a position in PGNY in Q4 2019 and held it in 10 quarters. The position peaked at $7.96M in Q3 2021. 247 funds tracked by Wall St. Rank hold PGNY as of Q2 2022.

  • Axiom Investors reported no remaining Progyny position as of Q2 2022 after selling out during the quarter.
  • Axiom Investors sold 104,637 Progyny shares in Q2 2022, an estimated $5.38M.
  • Axiom Investors first reported a position in Progyny in Q4 2019 and held it in 10 quarters.
  • Axiom Investors's Progyny position peaked at $7.96M in Q3 2021.
  • 247 funds tracked by Wall St. Rank held Progyny as of Q2 2022.

Based on Axiom Investors's 13F filing for Q2 2022, filed 11 Aug 2022.